• Über Taylor Wessing
  • Unsere Anwälte
  • Expertise
    • Branchen
        • Technologie-, Medien & Kommunikation
        • Private Wealth
        • Real Estate, Infrastructure & Energy
        • Life Sciences & Healthcare
        • Aerospace & Defence
        • Automobilindustrie & Mobilität
        • Business & Professional Services
        • Chemieindustrie
        • Konsumgüter und Einzelhandel
        • Bank- & Finanzwesen
        • Hotels, Hospitality & Leisure
        • Logistik & Transport
        • Industrieunternehmen
        • Öffentliche Dienste & Bildungsinfrastruktur
    • Rechtsgebiete
        • Künstliche Intelligenz
        • Bank- & Finanzrecht
        • Marken & Werbung
        • Handels- & Vertriebsrecht
        • Kartell-, Vergabe-, Beihilfe- und Außenhandelsrecht
        • Urheber- und Medienrecht
        • Wirtschaftsstrafrecht und Compliance
        • M&A / Gesellschaftsrecht & Kapitalmarktrecht
        • Daten & Cybersicherheit
        • Disputes & Investigations
        • Arbeitsrecht
        • Umwelt, Planung & Regulierung
        • Environmental, Social & Governance (ESG)
        • Informationstechnologie
        • Notariat & Geschäftsgeheimnisse
        • Patents Technology & Life Sciences
        • Private Client
        • Private Equity
        • Projects, Energy & Infrastructure
        • Immobilienrecht
        • Regulation
        • Restrukturierung & Insolvenzrecht
        • Steuerrecht
        • Venture Capital
  • International
    • Europa
        • Standorte
        • Österreich
        • Belgien
        • Tschechische Republik
        • Frankreich
        • Deutschland
        • Ungarn
        • Italy
        • Niederlande
        • Polen
        • Portugal
        • Republik Irland
        • Slowakei
        • Spanien
        • Großbritannien
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German Group
        • Unsere Büros
    • Naher Osten & Afrika
        • Standorte
        • Naher Osten
        • Vereinigte Arabische Emirate
          Groups
        • Africa Group
        • Israel Group
        • Unsere Büros
    • Amerika
        • Standorte
        • Latein Amerika
        • USA
          Groups
        • Brazil Group
        • Unsere Büros
    • Asien
        • Standorte
        • Asien
        • China
        • Südkorea
          Groups
        • India Group
        • Japan Group
        • Unsere Büros
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • EU-Whistleblower-Richtlinie (HinSchG)
        • Lieferkettengesetz
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: Digitales Tech-Magazin
        • Podcasts
        • Synapse
        • Alle Insights
    • Events
        • In Präsenz
        • Online
        • Alle Events
    • News
        • Media Center
        • Unternehmensmeldungen
        • Deal Meldungen
        • Alle News
  • Karriere
  • DE
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • Team
  • Jules Fabre
Jules Fabre
Jules Fabre

Jules Fabre

Taylor Wessing

Partner

  • Paris Frankreich
+33 1 72 74 03 33
vCard
E-Mail Call me
Featured award

IAM Patent 1000 2025

Silver Individuals : Litigation - "Jules is a genius from a legal and strategic standpoint. He can take on critical and complicated litigation projects, demonstrating his high level of organisation, diligence and ability to be on top of every detail in the case. Jules has a great understanding of the technical aspects as well as the law, and utilises this to provide excellent insight, tactical advice and superb advocacy. He is totally unpretentious, approachable, amiable and an overall joy to work with."

Scroll to featured award

Jules Fabre heads Taylor Wessing's patent department in Paris. He specialises in intellectual property, with a particular focus on patent and regulatory matters in the Life Sciences and pharmaceutical sector.

He has extensive experience handling complex French and cross border patent and SPC litigations, both in private practice and in­house and is often instructed by clients to handle the pan-European co-ordination of their patent litigations and market access strategies, in addition to representing them before French courts and the UPC. Jules was involved in the first ever branded versus generic patent litigation brought before the UPC.

ln addition to his previous experience in other international law firms (Hogan Lovells, Linklaters, Pinsent Masons), Jules was a Senior Counsel in the European IP and Regulatory Litigation team of a Teva Pharmaceuticals in London, where he coordinated pan-European launch strategies, patent litigations and settlements. This brings an in-depth understanding of the industry from the inside, which enables Jules to provide sound and commercially relevant advice, and a detailed knowledge of patent litigation in the various European jurisdictions.

Jules is Unified Patent Court (UPC) representative.

Expertise

Rechtsgebiete und Gruppen

Patents Technology & Life Sciences
Beilegung von Patent- & Know-how-Streitigkeiten
Erstellung & Verhandlung von Patent- & Know-how-Verträgen

Branchen

Automobilindustrie & Mobilität
Industrieunternehmen
Chemieindustrie
Life Sciences & Healthcare

Patent Perspective Quick Listens

A UPC and European patent litigation podcast.

Listen now

CV

Since 2025 Partner, Taylor Wessing
2023 - 2025 Partner, Pinsent Masons
2019 - 2023 Counsel, Pinsent Masons
2017 - 2019 Senior Counsel, European IP and Regulatory Litigation, Teva Pharmaceuticals in London
2014 – 2017 Senior Associate, Linklaters
2011 – 2014 Associate, Hogan Lovells
2012 Admitted to the Bar, Paris
2008 Master II Droit de la Propriété Intellectuelle, Concurrence, Distribution et Commerce, Centre d’Études Internationales de la Propriété Intellectuelle (Strasbourg)

Karriere

Since 2025 Partner, Taylor Wessing
2023 - 2025 Partner, Pinsent Masons
2019 - 2023 Counsel, Pinsent Masons
2017 - 2019 Senior Counsel, European IP and Regulatory Litigation, Teva Pharmaceuticals in London
2014 – 2017 Senior Associate, Linklaters
2011 – 2014 Associate, Hogan Lovells

Ausbildung

2012 Admitted to the Bar, Paris
2008 Master II Droit de la Propriété Intellectuelle, Concurrence, Distribution et Commerce, Centre d’Études Internationales de la Propriété Intellectuelle (Strasbourg)

Fremdsprachen

English

Awards

IAM Patent 1000 2025

Featured

Silver Individuals : Litigation - "Jules is a genius from a legal and strategic standpoint. He can take on critical and complicated litigation projects, demonstrating his high level of organisation, diligence and ability to be on top of every detail in the case. Jules has a great understanding of the technical aspects as well as the law, and utilises this to provide excellent insight, tactical advice and superb advocacy. He is totally unpretentious, approachable, amiable and an overall joy to work with."

IP Stars 2025

Patent Star

Chambers & Partners France 2025

Pharma/Life Sciences: Intellectual Property - "He is a brilliant intellectual property lawyer. I have learnt so much from him. He is really a great person and is assisting clients with a lot of care and oversight."

Chambers & Partners France 2025

Intellectual Property: Patents - "Jules is proficient and very good, with a good technical background. He is absolutely outstanding and has a deep knowledge of the French system, the law and the practice."

Mehr

Recommended individuals - “very happy with his work, he is a rising star”

Healthcare life sciences - "Jules Fabre is a star in patent litigation in France. He has an extremely high level of expertise in this area and is a pleasure to work with."

Intellectual Property: Patents : ‘Jules Fabre, Marina Jonon: in addition to their outstanding knowledge of the technical area and of local law, they have provided advice in a timely and clear manner, with strategic outlook and full discussion of the possible scenarios, and achieved a major victory in a pharma patent action being litigated across Europe. ’

News & Insights: Jules Fabre

Zu den Insights
Klicken Sie hier für Details
Patents Technology & Life Sciences

Preliminary injunctions in France

22. Oktober 2025

von mehreren Autoren

Open podcast
Patent Perspectives Quick Listens

Episode 10 - Marking the second anniversary of the UPC

In episode ten of Patent Perspectives, Paul England is joined by Amanda Ebbutt, Christian Dekoninck, Jules Fabre and Phillip Rektorschek.

9. Juni 2025

von mehreren Autoren

English

1 von 10 Podcasts

Klicken Sie hier für Details
Glass.Mapper.Sc.Fields.Image?.Alt
Patents Technology & Life Sciences

Taylor Wessing strengthens pan-European patent law offering with new team in Paris

7. Mai 2025

von mehreren Autoren

Klicken Sie hier für Details
Zu den Insights

Aktuelle News & Insights

Life Sciences & Healthcare

Update aus Berlin: Bundesregierung verschärft Kurs in der Cannabispolitik

5. November 2025
Briefing

von Kathleen Munstermann-Senff, LL.M. (Medizinrecht) und Dr. Martin Jäger

Klicken Sie hier für Details
Patents Technology & Life Sciences

Preliminary injunctions in Poland

5. November 2025
Briefing

von Bartosz Świdrak und Karolina Ciąglewicz

Klicken Sie hier für Details
Deutschland

JUVE Handbuch Wirtschaftskanzleien 2025/26: Taylor Wessing Deutschland bestätigt erneut 5-Sterne-Bewertungen

4. November 2025

von mehreren Autoren

Klicken Sie hier für Details
Life Sciences & Healthcare

Biotechnologie als Sicherheitsfrage: Warum Dual-Use-Kontrolle und lernende Regulierung über nationale Zukunftsfähigkeit entscheiden

3. November 2025
Quick read

von Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

Klicken Sie hier für Details
Automobilindustrie & Mobilität

German Batteries Implementation Act and the Automotive Industry – Essential Insights (Part 2) | TWheel

29. Oktober 2025
Briefing

von Dr. Ulrich Spiegel

Klicken Sie hier für Details
Life Sciences & Healthcare

Apothekenreform 2025 – Geplante Änderungen im Überblick

29. Oktober 2025
Briefing

von Kathleen Munstermann-Senff, LL.M. (Medizinrecht) und Dr. Lisa Rottmann, LL.M. (Medizinrecht)

Klicken Sie hier für Details
Patents Technology & Life Sciences

Preliminary injunctions in Belgium

29. Oktober 2025
Briefing

von mehreren Autoren

Klicken Sie hier für Details
Life Sciences & Healthcare

Healthcare unlimited – Telemedizin vor dem Durchbruch?

23. Oktober 2025
In-depth analysis

von Kathleen Munstermann-Senff, LL.M. (Medizinrecht) und Katharina Häberle

Klicken Sie hier für Details
Life Sciences & Healthcare

Advertising skinny jabs – regulators react

15. Oktober 2025
Quick read

von Alison Dennis und Alice Matthews

Klicken Sie hier für Details
Patents Technology & Life Sciences

Preliminary injunctions in Austria

15. Oktober 2025
Briefing

von mehreren Autoren

Klicken Sie hier für Details
Mehr

Weitere Beraterinnen und Berater

Frankreich
/Taylor Wessing/Images/People/Profiles/France/Jonon-Marina/Jonon-Marina-wit

Marina Jonon

Counsel

Paris
+33 1 72 74 03 33
E-Mail
Profil ansehen
/Taylor Wessing/Images/People/Profiles/France/Millot-Louise/Millot-Louise-wit

Louise Millot

Associate

Paris
+33 1 72 74 03 33
E-Mail
Profil ansehen
Clémence de Marassé-Enouf

Clémence de Marassé-Enouf

Associate

Paris
+33 1 72 74 03 33
E-Mail
Profil ansehen
Alle Beraterinnen und Berater

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.

Alle Events
Newsletter-Anmeldung
  • Über Taylor Wessing
  • Campaigns and online tools
  • News
  • Unsere Anwälte
  • Expertise
  • International
  • Insights
  • Events
  • Presse & News
  • Kontakt
  • Karriere
  • Alumni
  • Datenschutzhinweise
  • Datenschutzbestimmungen & Cookie Hinweise
  • Rechtliche und regulatorische informationen
  • Regulatorische Informationen zu Kosten
  • Beschwerdeverfahren für Mandanten
  • Nutzungsbedingungen
  • Anti-slavery Statement
  • Nachhaltigkeit
  • Scam E-Mails

© Taylor Wessing